Shingo Umemoto

Dr. Shingo Umemoto

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Auris Nasus Larynx
Verified
Journal Article
Open access
KTKaori Tateyama
Kaori Tateyama
SUShingo Umemoto
Shingo Umemoto
SIShohei Iwano
Shohei Iwano
THTakashi Hirano
Takashi Hirano
MSMasashi Suzuki
Masashi Suzuki
This study aimed to examine the characteristics of nasal and imaging findings of sinonasal lesions in granulomatosis with polyangiitis (GPA) patients and how these lesions change over time in both the active and remission phases of the disease. We retrospectively reviewed GPA patients with sinonasal lesions who were followed up at our department between January 2005 and December 2020. The following data were collected: age, sex, symptoms at initial presentation, anti-neutrophil cytoplasmic antibody (ANCA) type, and histopathological, nasal (initial and follow-up), and imaging (initial and follow-up) findings. This study included 17 patients with GPA aged 30 to 79 years. Computed tomography (CT) of the sinuses showed mucosal thickening in 16 patients, bone thickening in 12, bone destruction in 4, and an orbital invasion mass in 3 at the time of diagnosis. After initiating treatment, mucosal thickening of the sinuses improved in 3 of 16 patients and remained unchanged in 13. Bone thickening at the time of diagnosis remained unchanged in 10 of 12 patients and worsened in 2; 1 patient displayed newly developed bone thickening. Destructive nasal findings on CT were positive for proteinase 3-ANCA. Our study revealed that mucosal thickening, bone thickening, bone destruction, and orbital invasion mass were major CT findings in patients with GPA. Intranasal findings such as granulations, crusting, and necrosis were seen in the active phase; moreover, saddle nose, loss of turbinate, and nasal septal perforation were subsequently seen in the course of the disease. Sinonasal findings of GPA vary depending on the disease stage and period.

12 November 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
RNRika Nakahashi-Ouchida
Rika Nakahashi-Ouchida
HMHiromi Mori
Hiromi Mori
YYYoshikazu Yuki
Yoshikazu Yuki
TMTomonori Machita
Tomonori Machita
YKYuko Katakai
Yuko Katakai
HKHiroshi Kiyono
Hiroshi Kiyono
Therapeutic vaccines against cervical cancer caused by human papillomavirus (HPV) are still an unmet medical need, despite a prophylactic HPV vaccine being available, and the now-licensed systemic vaccines may have a limited effect on the reproductive tract. To specifically inhibit cervical cancer development, the concept of mucosal immunity based on the reproductive-respiratory axis was adopted to develop a nasal HPV therapeutic vaccine. We used a cationic nanogel for the nasal vaccine delivery system and targeted HPV16 E7, an oncoprotein in HPV-driven cervical cancer to demonstrate the feasibility of a nasal therapeutic vaccine. The vaccine was combined with cyclic di–adenosine monophosphate as a cell-mediated immunity-inducing adjuvant. Intranasal immunization with the nanogel vaccine induced E7-specific CD4 + and CD8 + T cells in mouse cervicovaginal tissue. An antitumor effect due to the infiltration of vaccine-induced E7-specific T cells was also observed in an orthotopic tumor model in mice. Furthermore, intranasal immunization of nonhuman primates with the nanogel vaccine using a spray device that is also applicable to humans induced E7-specific T cells in the reproductive tissues. Our findings demonstrated that this nasal therapeutic vaccine effectively controlled cervical cancer and will contribute to preclinical evidence for clinical testing in the near future.

13 March 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
KYKazuhiro Yoshinaga
Kazuhiro Yoshinaga
THTakashi Hirano
Takashi Hirano
SUShingo Umemoto
Shingo Umemoto
YKYoshinori Kadowaki
Yoshinori Kadowaki
TMTakayuki Matsunaga
Takayuki Matsunaga
MSMasashi Suzuki
Masashi Suzuki
Background/Objectives: Acute otitis media is a common pediatric infection caused primarily by nontypeable Haemophilus influenzae. With rising antibiotic resistance, vaccines are essential for combating this public health issue. Although the PD-1/PD-L1 pathway has been extensively studied for its role in tumor immunity, its impact on mucosal immunity, particularly in vaccine responses, is unclear. Methods: BALB/c mice were intranasally immunized with nontypeable H. influenzae outer membrane protein and treated with anti-PD-L1 antibodies. Immune responses were evaluated in middle ear mucosa (MEM), the cervical lymph node, and the spleen using an enzyme-linked immunosorbent assay, an enzyme-linked immunospot assay, and flow cytometry. The effects on CD4+ T cells, T follicular helper (Tfh) cells, and B-cell differentiation were analyzed. Results: Anti-PD-L1 antibody treatment increased CD3+CD4+CD185+ (CXCR5+) Tfh cells in MEM, which play a crucial role in supporting B-cell activation and antibody production. This correlated with a significant increase in IgA- and IgG-producing cells in MEM, which enhanced local bacterial clearance. Although B-cell activation and differentiation into plasmablasts were observed in MEM, no significant changes were noted in the cervical lymph node and spleen, suggesting a localized enhancement of mucosal immunity. Conclusions: Anti-PD-L1 antibodies promoted Tfh cell expansion and B-cell differentiation in MEM, leading to enhanced antibody production and improved bacterial clearance. These findings suggest that PD-L1 blockade can potentiate mucosal vaccine-induced immunity by strengthening local humoral responses. This supports its potential application in developing intranasal vaccines for acute otitis media.

8 July 2025
Verified
Journal Article
Open access
TMTakayuki Matsunaga
Takayuki Matsunaga
SUShingo Umemoto
Shingo Umemoto
THTakashi Hirano
Takashi Hirano
Adenoid cystic carcinoma (ACC) of the nasal septum is an exceedingly rare malignancy characterized by indolent but aggressive growth, frequent perineural invasion, and late-onset distant metastasis. Preoperative diagnosis can be challenging due to histopathologic similarities with benign salivary-type tumors. We report the case of a 75-year-old woman who presented with nasal obstruction and intermittent epistaxis. Nasal endoscopy identified a polypoid mass on the posterior nasal septum, and biopsy initially suggested a basal cell adenoma. Imaging revealed no evidence of perineural spread or skull base invasion. The patient underwent endoscopic resection with negative intraoperative margins. Final histopathological analysis confirmed cribriform-pattern ACC without perineural invasion. Given the patient’s comorbidities and family preference, adjuvant radiotherapy was not administered. Although the early postoperative course was uneventful, the patient developed local recurrence and cervical spine metastasis 52 months after surgery. She declined further treatment but remained alive with the disease at 72 months under observation. This case underscores the diagnostic complexity of nasal septum ACC and demonstrates the utility of endoscopic resection for localized tumors. However, in light of the delayed recurrence and close surgical margins typical of endoscopic approaches, the role of adjuvant radiotherapy should be carefully evaluated on an individual basis. Long-term follow-up is essential due to the potential for late recurrence and distant metastasis.

28 August 2026 in Acta Oto-Laryngologica Case Reports
Verified
Journal Article
Open access
KHKota Hiraoka
Kota Hiraoka
SUShingo Umemoto
Shingo Umemoto
AFAyako Fukui
Ayako Fukui
RTReo Tajiri
Reo Tajiri
SNSeiki Nobe
Seiki Nobe
THTakashi Hirano
Takashi Hirano
Vestibular neuritis (VN), also termed acute unilateral vestibulopathy (AUVP), is an acute peripheral vestibular syndrome caused by unilateral loss of peripheral vestibular function without evidence...